SINOPHARM's major retreat: Selling off more than 10 subsidiaries in a year, the "two-invoice system legacy" is no longer appealingHuxiu·1 day ago, 07:19 AM01099-1.19%
Multiple positive factors resonate in the pharmaceutical sector! Foreign capital opening + BIO conference support, innovative drugs CXO welcome explosive opportunitiesChina Finance Online·Jun 22 at 10:05 PM01099-1.19%600079-1.50%
SINOPHARM Group terminates the 4.7 billion acquisition, withdrawing from PLBIOQQ News·Jun 20 at 09:06 PM000403-5.14%600511-3.20%
Sinopharm Sets Final 2025 Dividend and Clarifies Withholding Tax for H-Share InvestorsTip Ranks·Jun 18 at 04:43 AM01099-1.19%
SINOPHARM will distribute a final dividend of RMB 0.69 per share on August 18Zhitong·Jun 18 at 04:09 AM01099-1.19%
Sinopharm declares final dividend of RMB 0.69 a share for FY2025PUBT·Jun 18 at 04:05 AM01099-1.19%000028-1.80%
According to the Hong Kong Stock Exchange disclosure, as of June 3, BlackRock's long position in SINOPHARM's H shares increased from 8.74% to 9.84%Zhitong·Jun 9 at 04:17 AM01099-1.19%BLK-74.00%
1.654 billion invested in AmoyDx, state-owned enterprise SINOPHARM enters the game to reshape the oncology IVD industry landscape腾讯新闻 - 财经·Jun 5 at 08:01 AM300685-4.32%000028-1.80%
CITIC Securities Asset Management Company reduced its holdings in SINOPHARM by 1.7752 million shares at an average price of approximately HKD 16.94 per shareZhitong·Jun 4 at 06:42 AM01099-1.19%06030-4.67%
FMR LLC reduced its holdings in SINOPHARM by approximately 5.9478 million shares at a price of about HKD 17.69 per shareZhitong·May 28 at 07:31 AM01099-1.19%
Sinopharm Sets 2025 AGM to Approve Dividend, Guarantees and Share Issuance MandateTip Ranks·May 27 at 05:58 PM01099-1.19%510660-2.73%
